ResMed
RMD
#671
Rank
$29.11 B
Marketcap
$197.94
Share price
0.82%
Change (1 day)
-8.29%
Change (1 year)
Categories

P/E ratio for ResMed (RMD)

P/E ratio as of March 2024 (TTM): 31.9

According to ResMed's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 31.8718. At the end of 2022 the company had a P/E ratio of 37.7.

P/E ratio history for ResMed from 2001 to 2023

PE ratio at the end of each year

Year P/E ratio Change
202237.7-48.18%
202172.865.33%
202044.0-9.98%
201948.935.24%
201836.1-13.78%
201741.955.41%
201627.025.12%
201521.6-3.84%
201422.48.6%
201320.60.84%
201220.582.2%
201111.2-53.77%
201024.36.96%
200922.7-3.59%
200823.6-63.65%
200764.981.83%
200635.7-5.04%
200537.636.71%
200427.52.51%
200326.86.95%
200225.1-78.16%
2001115

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
32.0 0.26%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
37.8 18.50%๐Ÿ‡บ๐Ÿ‡ธ USA
65.7 106.05%๐Ÿ‡บ๐Ÿ‡ธ USA
-0.0042-100.01%๐Ÿ‡บ๐Ÿ‡ธ USA
-1.90-105.96%๐Ÿ‡บ๐Ÿ‡ธ USA
-28.5-189.42%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.